Cell death and cell death responses in liver disease: mechanisms and clinical relevance

T Luedde, N Kaplowitz, RF Schwabe - Gastroenterology, 2014 - Elsevier
Hepatocellular death is present in almost all types of human liver disease and is used as a
sensitive parameter for the detection of acute and chronic liver disease of viral, toxic …

[PDF][PDF] Epidemiology of hepatocellular carcinoma in the United States: where are we? Where do we go?

HB El‐Serag, F Kanwal - Hepatology, 2014 - Wiley Online Library
The incidence of hepatocellular carcinoma (HCC) has almost tripled since the early 1980s in
the United States, where it is the fastest rising cause of cancerrelated deaths. 1 According to …

Hepatic immune regulation and its involvement in viral hepatitis infection

PA Knolle, R Thimme - Gastroenterology, 2014 - Elsevier
The liver has unique immune regulatory functions that promote the induction of tolerance
rather than responses to antigens encountered locally. These functions are mediated by …

Tackling the hepatitis B disease burden in India

P Puri - Journal of clinical and experimental hepatology, 2014 - Elsevier
Globally, approximately 240 people have been infected worldwide with hepatitis B Virus
(HBV). India has approximately HBV carrier rate of 3.0% with a high prevalence rate in the …

Virus associated malignancies: the role of viral hepatitis in hepatocellular carcinoma

A Shlomai, YP de Jong, CM Rice - Seminars in cancer biology, 2014 - Elsevier
Hepatocellular carcinoma (HCC) is the third leading fatal cancer worldwide and its
incidence continues to increase. Chronic viral hepatitis involving either hepatitis B virus …

Hepatocellular carcinoma: epidemiology and risk factors

MC Kew - Journal of hepatocellular carcinoma, 2014 - Taylor & Francis
Hepatocellular carcinoma is one of the major malignant tumors in the world today. The
number of new cases of the tumor increases year by year, and hepatocellular carcinoma …

[HTML][HTML] The diagnosis and treatment of hepatocellular carcinoma

NP Malek, S Schmidt, P Huber, MP Manns… - Deutsches Ärzteblatt …, 2014 - ncbi.nlm.nih.gov
Background The incidence of hepatocellular carcinoma (HCC) has continued to rise in
recent years. This increase has been attributed to alcohol-induced liver diseases, metabolic …

[HTML][HTML] Hepatitis B virus coinfection in human immunodeficiency virus-infected patients: a review

HY Sun, WH Sheng, MS Tsai, KY Lee… - World journal of …, 2014 - ncbi.nlm.nih.gov
Hepatitis B virus (HBV) infection is a leading cause of chronic hepatitis, liver cirrhosis, and
hepatocellular carcinoma worldwide. Due to the shared modes of transmission, coinfection …

[HTML][HTML] Hepatitis B virus: where do we stand and what is the next step for eradication?

H Komatsu - World journal of gastroenterology: WJG, 2014 - ncbi.nlm.nih.gov
Abstract Hepatitis B (HB) virus (HBV) infection, which causes liver cirrhosis and
hepatocellular carcinoma, is endemic worldwide. Hepatitis B vaccines became commercially …

[HTML][HTML] Novel aspects of the liver microenvironment in hepatocellular carcinoma pathogenesis and development

T Tu, MA Budzinska, AE Maczurek, R Cheng… - International journal of …, 2014 - mdpi.com
Hepatocellular carcinoma (HCC) is a prevalent primary liver cancer that is derived from
hepatocytes and is characterised by high mortality rate and poor prognosis. While HCC is …